Skip to main content
SupplementScience

Benefits of Sulbutiamine

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Superior brain thiamine delivery — sulbutiamine raises brain thiamine pyrophosphate (TPP) levels significantly higher than equivalent doses of thiamine, due to its lipophilic structure enabling BBB penetration
  • Anti-fatigue effects — Arcalion (sulbutiamine) was prescribed in France specifically for asthenia (chronic fatigue); a clinical trial showed significant improvements in fatigue scores in post-infectious asthenia patients
  • Dopamine modulation — sulbutiamine upregulates D1 dopamine receptor density in the prefrontal cortex, supporting motivation, drive, and reward-seeking behavior
  • Memory enhancement — Micheau et al. (1985) demonstrated that sulbutiamine improves long-term memory formation in rodent models through potentiation of cholinergic and glutamatergic signaling
  • Erectile dysfunction — a small trial found sulbutiamine at 600mg/day improved psychogenic erectile dysfunction in 16 of 20 patients, likely through central dopaminergic mechanisms

What the Research Says

Sulbutiamine was developed in Japan and gained clinical use in France as Arcalion for asthenia. Its pharmacological profile — superior BBB penetration, dopaminergic modulation, and cholinergic potentiation — has been characterized in preclinical studies (Micheau et al., 1985). Clinical data is limited to small trials and post-marketing surveillance from its use as Arcalion. Its anti-fatigue effects are the most clinically validated benefit. The nootropic community values it primarily for motivation enhancement via dopamine receptor upregulation.

Related Conditions

Brain FogFocusEnergy
Full Sulbutiamine Guide

References

  1. (). Chronic administration of sulbutiamine improves long term memory formation in mice: possible cholinergic mediation. Pharmacology Biochemistry and Behavior. DOI
  2. (). Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo. La Revue de Médecine Interne. DOI
  3. (). Clinical efficacy of the drug sulbutiamine in the treatment of erectile dysfunction in patients with psychogenic and mixed organic etiology. Urologiia.